Alloy Therapeutics
Alloy Therapeutics Biologics Drug Discovery Technologies and Services
United States · $157.0M raised
- Employees
- 51–200
- Business Model
- B2B
- Website
- alloytx.com
- Total Funding
- $157.0M
- Last Round
- $42.0M Series DApr 2026
- Rounds
- 4
About
Alloy Therapeutics democratizes access to antibody and biologics discovery technology to enable and advance drug discovery globally.
Summary
Alloy Therapeutics is a Biotech company based in United States. It has raised $157.0M in total across 4 rounds, most recently a $42.0M Series D round in Apr 2026. Investors include 8VC, JIC Venture Growth Investments and Echo Capital Group.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2026
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...